Published in Br J Clin Pharmacol on April 01, 1989
Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension. Br J Clin Pharmacol (1990) 0.75
Control of blood pressure in hypertensive patients with felodipine extended release or nifedipine retard. Br J Clin Pharmacol (1990) 0.75
The two-period cross-over clinical trial. Br J Clin Pharmacol (1979) 13.21
To be taken as directed. J R Coll Gen Pract (1968) 3.54
Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. JAMA (1977) 2.60
Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients. J Cardiovasc Pharmacol (1984) 1.01
Efficacy of nitrendipine as baseline antihypertensive therapy. J Cardiovasc Pharmacol (1984) 0.91
Salt saga continued. BMJ (1988) 2.66
Guidelines on guidelines. J Hypertens (1993) 2.11
Hydrallazine in hypertension: is there a safe dose? Br Med J (1980) 1.99
Medical ethics: some reservations. J Med Ethics (1982) 1.98
Do we need more anti-hypertensive drugs: lessons from the new biology. Lancet (1995) 1.65
First line treatment in hypertension. BMJ (1990) 1.58
Salt and hypertension. Lancet (1984) 1.52
Value of ambulatory intra-arterial blood pressure monitoring in the long-term prediction of left ventricular hypertrophy and carotid atherosclerosis in essential hypertension. J Hum Hypertens (1999) 1.49
Evidence-based medicine and hypertension. J Hypertens (1999) 1.43
Antihypertensive drugs and plasma lipids. Br Heart J (1991) 1.42
Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation (2001) 1.26
Leucocyte membrane sodium transport in normotensive populations: dissociation of abnormalities of sodium efflux from raised blood-pressure. Lancet (1982) 1.26
Pulse pressure and resistance artery structure in the elderly. Hypertension (1995) 1.23
Further observations on renal transplants in man from cadaveric donors. Br Med J (1966) 1.22
Ion transport in hypertension. Biosci Rep (1982) 1.21
Racial variation in cardiovascular morbidity and mortality in essential hypertension. Heart (2000) 1.17
Treating hypertension. J Hypertens (1996) 1.17
Dietary salt and hypertension. Lancet (1980) 1.16
Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res (1987) 1.13
Thoughts on the Reith lectures. Lancet (1981) 1.12
Influence of dietary linoleic acid on leucocyte sodium transport and blood pressure. Br Med J (Clin Res Ed) (1986) 1.11
Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor. Circ Res (1978) 1.11
Magnesium deficiency and diuretics. Br Med J (Clin Res Ed) (1982) 1.10
Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation (1999) 1.09
Arterial wall or plasma renin in hypertension? Clin Sci (Lond) (1979) 1.07
Salt substitutes and potassium intake. BMJ (1991) 1.05
Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat. Clin Sci (Lond) (1980) 1.04
Abnormal vascular phosphoinositide hydrolysis in the spontaneously hypertensive rat. Br J Pharmacol (1986) 1.01
The dntidiuretic action of diazoxide. Clin Sci (1972) 1.01
Hyperaluminaemia form aluminium resins. Lancet (1970) 0.98
Abnormal baroreceptor-cardiac reflex sensitivity is not detected by conventional tests of autonomic function in patients with insulin-dependent diabetes mellitus. Clin Sci (Lond) (1996) 0.97
Treatment of refractory hypertension. Lancet (1982) 0.94
Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet (1995) 0.93
Expression of the renin gene in extra-renal tissues of the rat. Biochem J (1988) 0.93
Blood pressure response of nephrectomized hypertensive rats to converting enzyme inhibition: evidence for persistent vascular renin activity. Clin Sci Mol Med (1977) 0.92
Reversal of two-kidney one clip renovascular hypertension in the rat. Hypertension (1980) 0.90
Vascular renin-like activity and blood pressure maintenance in the rat. Studies of the effect of changes in sodium balance, hypertension and nephrectomy. Hypertension (1980) 0.90
Aluminium and chronic renal failure. Br Med J (1971) 0.89
Salt intake and diuretic treatment of hypertension. Lancet (1979) 0.89
Low renin hypertension. A distinct entity. Lancet (1976) 0.88
Assessment of baroreceptor-cardiac reflex sensitivity using time domain analysis in patients with IDDM and the relation to left ventricular mass index. Diabetologia (1996) 0.88
Plasma renin and angiotensin II measurement in hypertensive and normal subjects: correlation of basal and stimulated states. J Clin Endocrinol Metab (1977) 0.88
Detection of renin messenger RNA in rat tissues: increased sensitivity using an RNAse protection technique. J Hypertens Suppl (1987) 0.87
Erythraemia in renal transplantation. Br Med J (1969) 0.87
Studies of isolated resistance vessels from offspring of essential hypertensive patients. Hypertension (1987) 0.87
Guidelines for management of hypertension. Sticking to guidelines can be expensive. BMJ (1994) 0.87
Sodium conservation in chronic renal failure: studies using oral diazoxide. Clin Sci (1972) 0.87
Aluminium retention and toxicity in chronic renal failure. Lancet (1972) 0.86
Arterial wall uptake of renal renin and blood pressure control. Hypertension (1983) 0.86
Vascular angiotensin II receptors and sodium balance in rats. Role of kidneys and vascular renin activity. Circ Res (1975) 0.86
The influence of pH, bicarbonate and hypertonicity on the absorption of ammonia from the rat intestine. Clin Sci (1970) 0.86
Dangers in treating hyponatremia. Br Med J (Clin Res Ed) (1987) 0.85
Calcium antagonists in hypertension: relation to abnormal sodium transport. Br Med J (Clin Res Ed) (1983) 0.85
Healed experimental renal papillary necrosis. J Pathol (1973) 0.85
Effects of treatment for hypertension on cerebral haemorrhage and infarction. Br Med J (Clin Res Ed) (1984) 0.84
Improvement of renal function during long-term treatment of severe hypertension with minoxidil. Q J Med (1983) 0.84
Pulse pressure and prognosis. Heart (2001) 0.84
Intestinal ammonia in uraemia: the effect of a urease inhibitor, acetohydroxamic acid. Clin Sci (1972) 0.83
Cell membrane sodium transport: a correlation between human resistance vessels and leucocytes. Lancet (1986) 0.83
Hypertension produced by chemical renal medullectomy: evidence for a renomedullary vasodepressor function in the rat. Clin Sci (Lond) (1984) 0.83
Histochemical changes associated with ischaemic damage to kidneys. Br J Exp Pathol (1966) 0.83
Effects of changes in dietary sodium intake on aortic sodium pump activity in the rat. Clin Sci (Lond) (1987) 0.83
Reversible hypertension and hypothyroidism. Clin Endocrinol (Oxf) (1980) 0.83
Noradrenaline stimulation of the phosphoinositide system: evidence for a novel hydrophobic inositol-containing compound in resistance arterioles. Br J Pharmacol (1988) 0.83
Arterial wall renin. J Hypertens Suppl (1983) 0.83
Combined prazosin and hydralazine in resistant hypertension. Lancet (1980) 0.83
Sodium metabolism in relation to changing blood pressure levels in human renal transplantation. Am J Med Sci (1967) 0.83
The addition of prazosin to standard triple therapy in the treatment of severe hypertension. Br J Clin Pharmacol (1982) 0.82
Changes in leucocyte sodium transport in normotensive relatives of hypertensive subjects. Dissociation from blood pressure. Hypertension (1984) 0.81
A widespread abnormality of renin gene expression in the spontaneously hypertensive rat: modulation in some tissues with the development of hypertension. Clin Sci (Lond) (1989) 0.81
Responsiveness to pressor agents in experimental renovascular and steroid hypertension. Effects of converting enzyme inhibitor and nephrectomy. Hypertension (1982) 0.81
Membrane transport of ions in hypertension: a review. Scand J Clin Lab Invest Suppl (1986) 0.80
Low-renin hypertension: nephrosclerosis? Lancet (1975) 0.80
Effects of manipulation of sodium balance on erythrocyte sodium transport. J Hum Hypertens (1987) 0.80
Sodium balance during the development of experimental hypertension. J Lab Clin Med (1972) 0.80
Generation of angiotensin II at peripheral vascular level: studies using angiotensin II antisera. Clin Sci Mol Med (1973) 0.80
Effect of unclipping on pressor responses in rats with renovascular hypertension. Clin Sci (Lond) (1984) 0.80
Renin subgroups in essential hypertension: an analysis and critique. Q J Med (1978) 0.80
Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat. Clin Sci (Lond) (1980) 0.80
Kidney renin mRNA levels in the early and chronic phases of two-kidney, one clip hypertension in the rat. J Hypertens (1989) 0.79
Hemodynamic changes induced by reversal of early and late renovascular hypertension. Am J Physiol (1983) 0.79
Endothelial function in subcutaneous resistance arteries from elderly hypertensive and normotensive subjects. Clin Sci (Lond) (1997) 0.79
Plasma renin in hypertensive patients: significance in relation to clinical and other biochemical features. Q J Med (1980) 0.79
Experimental renal papillary necrosis: progressive changes on intravenous urography. Invest Radiol (1971) 0.79
Abnormalities of erythrocyte membrane fatty acid composition in human essential hypertension. J Hum Hypertens (1987) 0.79
Renal failure after cholangiography. Br Med J (1967) 0.78
Molecular biology of the vascular renin-angiotensin system. Blood Vessels (1991) 0.78
Endothelial-dependent relaxation in human subcutaneous resistance vessels. Blood Vessels (1987) 0.78
A major structural abnormality in the renin gene of the spontaneously hypertensive rat. J Hypertens (1989) 0.78
DNA fingerprinting of spontaneously hypertensive and Wistar-Kyoto rats: implications for hypertension research. J Hypertens (1989) 0.78
Ion transport in hypertension: are changes in the cell membrane responsible? Clin Sci (Lond) (1986) 0.77
Hypertension with renal impairment: influence of intensive therapy. Q J Med (1974) 0.77
Pathophysiology of blood pressure in the elderly. Age Ageing (1979) 0.77
Influence of sodium restriction upon two models of renal hypertension. Clin Sci Mol Med (1976) 0.77
Alcohol, blood pressure and hypertension. Novartis Found Symp (1998) 0.77
Baroreceptor-heart rate reflex function before and after surgical reversal of two-kidney, one-clip hypertension in the rat. Circ Res (1990) 0.77
Plasma renin in long-term diuretic treatment of hypertension: effect of discontinuation and restarting therapy. Clin Sci (Lond) (1982) 0.77
Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype. Q J Med (1987) 0.77
A photoelectric method of blood pressure measurement in the rat. J Lab Clin Med (1970) 0.77
The relation between blood-pressure level and ischaemic renal contraction in the rat. J Pathol (1970) 0.77